Waterworth DM, Jansen H, Nicaud V, Humphries SE, Talmud PJ (2005)
Interaction between insulin (VNTR) and hepatic lipase (LIPC-514C>T) variants on the response to an oral glucose tolerance test in the EARSII group of young healthy men
Biochimica & Biophysica Acta 1740: 375

Deakin S, Leviev I, Nicaud V, Brulhart Meynet MC, Tiret L, James RW (2002)
Paraoxonase-1 L55M polymorphism is associated with an abnormal oral glucose tolerance test and differentiates high risk coronary disease families
J Clinical Endocrinology Metab 87: 1268

Leviev I, Poirier O, Nicaud V, Evans A, Kee F, Arveiler D, Morrisson C, Cambien F, James RW (2002)
High expressor paraoxonase PON1 gene promoter polymorphisms are associated with reduced risk of vascular disease in younger coronary patients
Atherosclerosis 161: 463

Jansen H, Chu G, Ehnholm C, Dallongeville J, Nicaud V, Talmud PJ (1999)
The T allele of the hepatic lipase promoter variant C-480T is associated with increased fasting lipids and HDL and increased preprandial and postprandial LpCIII:B : European Atherosclerosis Research Study (EARS) II
Arterioscler Thromb Vasc Biol 19: 303

Humphries SE, Nicaud V, Margalef J, Tiret L, Talmud PJ (1998)
Lipoprotein lipase gene variation is associated with a paternal history of premature coronary artery disease and fasting and postprandial plasma triglycerides: the European Atherosclerosis Research Study (EARS)
Arterioscler Thromb Vasc Biol 18: 526

Gerdes C, Fisher RM, Nicaud V, Boer J, Humphries SE, Talmud PJ, Faergeman O (1997)
Lipoprotein lipase variants D9N and N291S are associated with increased plasma triglyceride and lower high-density lipoprotein cholesterol concentrations: studies in the fasting and postprandial states: the European Atherosclerosis Research Studies
Circulation 96: 733

Mailly F, Fisher RM, Nicaud V, Luong LA, Evans AE, Marques-Vidal P, Luc G, Arveiler D, Bard JM, Poirier O, Talmud PJ, Humphries SE (1996)
Association between the LPL-D9N mutation in the lipoprotein lipase gene and plasma lipid traits in myocardial infarction survivors from the ECTIM Study
Atherosclerosis 122: 21